Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 1/20 | 0.39 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.30 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14828404 | 0.86 | — | — | |
| SCHEMBL23946276 | 0.86 | — | — | |
| SCHEMBL4904117 | 0.86 | — | — | |
| SCHEMBL21276522 | 0.84 | EPAS1 (0.42) | EPAS1SLC18A3SIGMAR1 | |
| SCHEMBL3959007 | 0.84 | EPAS1 (0.47) | EPAS1SLC18A3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL18249041 | 0.84 | — | — | |
| SCHEMBL14158242 | 0.82 | EPAS1 (0.46) | EPAS1SLC18A3SIGMAR1 | |
| SCHEMBL1723503 | 0.79 | — | — | |
| SCHEMBL606385 | 0.79 | — | — | |
| SCHEMBL1724943 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0145121-B1 | PYRAZOLOQUINOLINES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ELI LILLY AND COMPANY (US) | 1991-08-14 | — | — | EP | disclosed |
| US-4778894-A | TRANS-OCTAHYDROPYRAZOLOQUINOLINES; INTERMEDIATES FOR HYPOTENSIVE AGENTS | ELI LILLY AND COMPANY (US) | 1988-10-18 | — | — | US | disclosed |
| EP-0127708-B1 | TRANS-DL-1-ALKYL-6-ALKOXYOCTAHYDROQUINOLINES | ELI LILLY AND COMPANY (US) | 1987-09-09 | — | — | EP | disclosed |
| US-4626591-A | Trans-dl-1-alkyl-6-alkoxy-1,2,3,4,4a,5,8,8a octa-hydroquinolines | ELI LILLY AND COMPANY (US) | 1986-12-02 | — | — | US | disclosed |
| US-4596871-A | Tautomeric mixtures | ELI LILLY AND COMPANY (US) | 1986-06-24 | — | — | US | disclosed |
| US-4540787-A | Method of preparing trans-D1-1-alkyl-6-oxodecahydroquinolines | ELI LILLY AND COMPANY (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0145121-A2 | Pyrazoloquinolines, process for their preparation, and pharmaceutical compositions containing them | ELI LILLY AND COMPANY (US) | 1985-06-19 | — | — | EP | disclosed |
| EP-0142920-A2 | 6-Oxodecahydroquinolines and process for their preparation | ELI LILLY AND COMPANY (US) | 1985-05-29 | — | — | EP | disclosed |
| EP-0127708-A1 | Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines | ELI LILLY AND COMPANY (US) | 1984-12-12 | — | — | EP | disclosed |
| EP-0013788-B1 | OCTAHYDRO-2H-PYRROLO(3,4-G)QUINOLINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ELI LILLY AND COMPANY (US) | 1983-04-27 | — | — | EP | disclosed |
| US-4311844-A | Octahydro-2H-pyrrolo[3,4,-g]quinolines | ELI LILLY AND COMPANY (US) | 1982-01-19 | — | — | US | disclosed |
| US-4282362-A | TREATING PARKINSON'S DISEASE, INHIBITORS OF PRE ACTIN SECRETION, DOPAMINE ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1981-08-04 | — | — | US | disclosed |
| US-4282362-A | TREATING PARKINSON'S DISEASE, INHIBITORS OF PRE ACTIN SECRETION, DOPAMINE ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1981-08-04 | — | — | US | disclosed |
| US-4235909-A | DOPAMINE ANTAGONISTS, IN THE TREATMENT OF PARKINSON'S DISEASE | ELI LILLY AND COMPANY (US) | 1980-11-25 | — | — | US | disclosed |
| US-4235909-A | DOPAMINE ANTAGONISTS, IN THE TREATMENT OF PARKINSON'S DISEASE | ELI LILLY AND COMPANY (US) | 1980-11-25 | — | — | US | disclosed |
| EP-0013788-A1 | Octahydro-2H-pyrrolo(3,4-g)quinolines, process for their preparation and pharmaceutical compositions containing them | ELI LILLY AND COMPANY (US) | 1980-08-06 | — | — | EP | disclosed |
| EP-0013788-A1 | Octahydro-2H-pyrrolo(3,4-g)quinolines, process for their preparation and pharmaceutical compositions containing them | ELI LILLY AND COMPANY (US) | 1980-08-06 | — | — | EP | disclosed |